SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Astellas Presents Zolbetuximab Use Data in 63 Patients

Astellas presented data on zolbetuximab use in 63 patients with gastric or gastroesophageal cancer in Canada.

Related stories